Dian Diagnostics Group Co.,Ltd. (300244.SZ)

CNY 12.69

(-0.47%)

Market Cap (In CNY)

7.76 Billion

Revenue (In CNY)

13.4 Billion

Net Income (In CNY)

307.46 Million

Avg. Volume

9.33 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
8.9-24.42
PE
-
EPS
-
Beta Value
0.581
ISIN
CNE1000015N1
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Mr. Haibin Chen B.S. (EMBA)
Employee Count
-
Website
https://www.dazd.cn
Ipo Date
2011-07-19
Details
Dian Diagnostics Group Co.,Ltd. operates as a third-party independent medical diagnostic service company in China. It offers medical diagnosis solutions for various general hospitals and specialty hospitals, community health service centers, township health centers, physical examination centers, disease prevention and control centers, and other medical and health institutions. The company operates 40 chain laboratories worldwide. It also engages in the research, development, and production of in vitro diagnostic reagents and related equipment and consumables; provision of medical equipment, drugs, clinical samples, biological products, virus and microorganisms, finished blood, live animals, compounds, and diagnostic reagents, as well as other cold chain transportation, warehousing services, cold chain product sales, and technical services. The company was formerly known as Zhejiang DIAN Diagnostics Co., Ltd. and changed its name to Dian Diagnostics Group Co.,Ltd. in November 2017. Dian Diagnostics Group Co.,Ltd. was founded in 2001 and is based in Hangzhou, China.